Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36547975

Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2023 Feb 1
First author
Cheung IY

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Cheung IY
      type
      Author
    2. name
      Mauguen A
      type
      Author
    3. name
      Modak S
      type
      Author
    4. name
      Ragupathi G
      type
      Author
    5. name
      Basu EM
      type
      Author
    6. name
      Roberts SS
      type
      Author
    7. name
      Kushner BH
      type
      Author
    8. name
      Cheung NK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Cheung IY
      type
      Author
    2. name
      Mauguen A
      type
      Author
    3. name
      Modak S
      type
      Author
    4. name
      Ragupathi G
      type
      Author
    5. name
      Basu EM
      type
      Author
    6. name
      Roberts SS
      type
      Author
    7. name
      Kushner BH
      type
      Author
    8. name
      Cheung NK
      type
      Author
    bibliography ids
    1. nci-bib-259a6ef8c8effc1c5f61bf45
    book metadata
    content sha256
    3a6c812a04bfa9aec17a5ff3d251792cbaa9d4689c65f4355c0204d508d34f3a
    document type
    citation
    dois
    1. 10.1001/jamaoncol.2022.5999
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36547975
    immutable id
    pubmed:36547975@3a6c812a04bfa9aec17a5ff3d251792cbaa9d4689c65f4355c0204d508d34f3a
    journal
    abbreviation
    JAMA Oncol
    issn electronic
    2374-2445
    issn print
    2374-2437
    issue
    2
    name
    JAMA oncology
    nlm unique id
    101652861
    pages
    242-250
    volume
    9
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36547975
      provenance
      batch id
      d370e99271168e8a8a13
      provider
      NCBI PubMed ESummary
      record sha256
      82e2bf50259dca5ca1fbb0769b39ea28f51adb07f63a504dfafdc11bbf171eb5
      response sha256
      f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
      retrieved at
      2026-09-09T23:48:13.005737+00:00
      publication date
      display
      2023 Feb 1
      precision
      day
      year
      2023
      publication types
      1. Randomized Controlled Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36547975/
      title
      Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.

      Preserved source evidence · Not medical advice